The Journal of Pediatrics
Volume 152, Issue 3 , Pages 394-399.e2, March 2008

Modafinil Improves Symptoms of Attention-Deficit/Hyperactivity Disorder across Subtypes in Children and Adolescents

  • Joseph Biederman, MD

      Affiliations

    • From the Pediatric Psychopharmacology Unit, Massachusetts General Hospital, Boston, MA
    • Dr Biederman receives research support from the following sources: Shire, Eli Lilly, Pfizer, McNeil, Abbott, Bristol-Myers-Squibb, New River Pharmaceuticals, Cephalon, Janssen, Neurosearch, Stanley Medical Institute, Novartis, Lilly Foundation, Prechter Foundation, National Institutes of Mental Health, National Institute of Child Health and Human Development, and National Institute on Drug Abuse. Dr Biederman is a speaker for the following speakers’ bureaus: Shire, Lilly, McNeil, Cephalon, UCB Pharma, and Novartis. Dr Biederman is on the advisory board of the following pharmaceutical companies: Eli Lilly, Shire, McNeil, Janssen, Novartis, and Cephalon.
    • Corresponding Author InformationReprint requests: Joseph Biederman, MD, Massachusetts General Hospital, Pediatric Psychopharmacology Unit, Yawkey Center for Outpatient Care, YAW-6A-6900, 32 Fruit St., Boston, MA 02114.
  • ,
  • Steven R. Pliszka, MD

      Affiliations

    • University of Texas Health Science Center, San Antonio, TX.
    • Dr Pliszka receives research support from Eli Lilly and Cephalon and is a speaker for speakers’ bureaus sponsored by Shire and McNeil.

Received 12 June 2006; received in revised form 20 June 2007; accepted 27 July 2007. published online 25 October 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The research detailed in this manuscript was funded by Cephalon, Inc.

PII: S0022-3476(07)00748-2

doi:10.1016/j.jpeds.2007.07.052

The Journal of Pediatrics
Volume 152, Issue 3 , Pages 394-399.e2, March 2008